| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/10/2007 | CA2121599C Monoclonal antibodies directed against the microtubule-associated protein tau |
| 04/10/2007 | CA2102447C Cyclopeptides |
| 04/05/2007 | WO2007038733A1 Method for enhancing effects of colorants and conditioners |
| 04/05/2007 | WO2007038172A2 Guanidinium carriers |
| 04/05/2007 | WO2007037133A1 Method for evaluation of compound capable of acting on plk3 |
| 04/05/2007 | WO2007036638A1 Cd4+ t survivin epitopes and uses thereof |
| 04/05/2007 | WO2007020386A3 Apoe mimetic agents |
| 04/05/2007 | WO2006122652A3 Thiosuccinic acid derivatives and the use thereof |
| 04/05/2007 | WO2006105392A3 Neuron targeting peptides |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078258 Purification process |
| 04/05/2007 | US20070078079 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
| 04/05/2007 | US20070078078 Core moiety such as 1,4,8,11-tetraazacyclotetradecane with a plurality of side chains containing guanidinium groups; conjugated to antigens, peptides, tumor antigens, anticancer agents, antimicrobials |
| 04/05/2007 | US20070077651 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077195 "N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination" |
| 04/05/2007 | CA2624498A1 Cd4+ t survivin epitopes and uses thereof |
| 04/05/2007 | CA2620051A1 Method for enhancing effects of colorants and conditioners |
| 04/04/2007 | EP1768994A2 Cyclic peptide antibiotics |
| 04/04/2007 | EP1768951A2 Non-natural amino acids |
| 04/04/2007 | EP1768688A2 Oral vaccine for borrelia |
| 04/04/2007 | EP1573323A4 Prion protein ligands and methods of use |
| 04/04/2007 | CN1942202A Identification of self and non-self antigens implicated in autoimmune diseases |
| 04/04/2007 | CN1308343C Process for preparing thymopentin |
| 04/03/2007 | US7199268 Process for the production of dendritic trimesic acid triamides |
| 04/03/2007 | US7199248 Process |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199215 Pseudopeptide, synthesis method, reagent and applications |
| 04/03/2007 | US7199102 Orally administered peptides synergize statin activity |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7199099 Treating grampositive bacterial infections |
| 04/03/2007 | US7198892 Hepatitis-C virus type 4, 5 and 6 |
| 04/03/2007 | US7198782 Using receptor binding peptide to treat and prevent pancreatic disorders; peptide mimetics; antidiabetic agents |
| 04/03/2007 | CA2362193C Volatilizable solid phase supports for compound synthesis |
| 04/03/2007 | CA2259950C Radiometal-binding peptide analogues |
| 04/03/2007 | CA2157530C Somatostatin analogs containing chelating groups and their radiolabeled compositions |
| 04/03/2007 | CA2121559C Immunogenic artificial polypeptide |
| 03/29/2007 | WO2007034678A1 Novel antifungal agent |
| 03/29/2007 | WO2007009946A3 Process for the manufacture of eptifibatide |
| 03/29/2007 | WO2006073771A3 Polyethylene glycol linked mc4r or mc3r agonist peptides |
| 03/29/2007 | WO2005120558A3 Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease |
| 03/29/2007 | US20070073043 Process for producing humanized chimera antibody |
| 03/29/2007 | US20070073039 Peptides that inhibit viral infections |
| 03/29/2007 | US20070072808 Antimicrobial and anticancer lipopeptides |
| 03/29/2007 | US20070072806 Inhibitor of the folding of the HIV-1-protease as antiviral agent |
| 03/29/2007 | US20070072805 Fusion peptide-induced hemolysis effectively inhibited by peptides of the invention compared to virus-inhibitory peptide (VIRIP); peptide blocks cellular infection by HIV particles by interacting with the fusion peptide of HIV viral glycoprotein 41 (gp41) to prevent virus entry into thecell |
| 03/29/2007 | US20070072802 Peptide nucleic acid based guanidinium compounds |
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072791 Polypeptides biodrugs with given amino acid sequence which includes phosphorylated serine or threonine; Type II Diabetes and Alzheimer's Disease |
| 03/29/2007 | US20070072251 In vivo imaging using peptide derivatives |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071677 Non-toxic membrane-translocating peptides |
| 03/29/2007 | CA2618282A1 Method for enhancing the effect of particulate benefit agents |
| 03/28/2007 | EP1767646A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767542A2 HLA-A2. 1 binding peptides and their uses |
| 03/28/2007 | EP1767541A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein |
| 03/28/2007 | EP1766011A1 Polypeptide ligands containing linkers |
| 03/28/2007 | EP1765862A2 Heparin binding peptide |
| 03/28/2007 | EP1765861A2 Fgfr binding peptides |
| 03/28/2007 | EP1765852A1 Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (psp94) family member |
| 03/28/2007 | EP1765851A2 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification |
| 03/28/2007 | EP1765374A2 Compositions, methods and uses for a novel family of peptides |
| 03/28/2007 | EP1554305B1 Prion protein-binding peptide sequences |
| 03/28/2007 | CN1938332A Inhibitors of serine proteases, particularly HCV NS3-HS4A protease |
| 03/28/2007 | CN1938041A Influenza virus-infection inhibitor |
| 03/28/2007 | CN1935833A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 03/27/2007 | US7196163 Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| 03/27/2007 | US7196162 Anti-aging and wound healing compounds |
| 03/27/2007 | US7196161 Administering 3-[(R)-2-(N,N-dimethylamino)ethylthio-Sarcosine]-4-(gamma hydroxymethylleucine)cyclosporin, or salts or hydrates thereof; also treating individuals co-infected with HIV; improved nephrotoxicity and/or hepatotoxicity |
| 03/27/2007 | US7196061 cyclic peptides and peptidomimetic used as agonists or antagonists of tyrosine kinase receptors; modulation of growth and repair of the central nervous system |
| 03/27/2007 | US7196055 Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor |
| 03/27/2007 | US7195884 Using peptide substrates to measure enzyme activity; enzyme inhibitors; modulators |
| 03/22/2007 | WO2007031741A1 Pseudomonas exotoxin a cd4+ t-cell epitopes |
| 03/22/2007 | WO2007030937A2 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 03/22/2007 | WO2007006548A3 Antibacterial amide macrocycles vii |
| 03/22/2007 | WO2006103356A3 Use of compounds inducing synthesis of sirt proteins in or for preparing a cosmetic or pharmaceutical composition |
| 03/22/2007 | WO2006096800A3 Immunogenic t cell targets in autoimmune hepatitis and methods of use |
| 03/22/2007 | WO2006078421A3 Methods of increasing cerebral blood flow |
| 03/22/2007 | US20070066813 Immunoglobulin fusion comprising blood glycoprotein with reduced glycosylation for use in prevention and treatment of septic shock, cachexia, viral and parasitic infection, autoimmune, arthritic and/or graft rejection |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066538 Treatment of wounds |
| 03/22/2007 | US20070066534 Comprising a polypeptide conjugated to one or more lipid moieties; synthetic; highly soluble; contraceptive agent ; vaccine |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070066516 Compounds comprising cyclized somatostatin receptor binding peptides |
| 03/22/2007 | US20070065908 antiinflammatories, antiviral agents; coadministering with antibiotic; surface decontamination |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065804 Method for PR-39 peptide mediated selective inhibition of IkappaBalpha degradation |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | US20070065362 Gastrin receptor-avid peptide conjugates |
| 03/22/2007 | CA2622525A1 Pseudomonas exotoxin a cd4+ t-cell epitopes |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1696945A4 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 03/21/2007 | EP1334195B1 Analogues, agonists, antagonists and variants of the oxidoreductase enzyme activity of the macrophage-migration inhibition factor (mif) as immunomodulators, medicaments, diagnostics and screening agents in inflammatory and immune diseases |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP0902839B1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 03/21/2007 | EP0865446B1 Agents for promoting bone formation |
| 03/21/2007 | CN1931359A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931358A Orally administered peptides to ameliorate atherosclerosis |